Tamoxifen-loaded lecithin organogel (LO) for topical application: Development, optimization and characterization

International Journal of Pharmaceutics

Volumn 444, Issue 1-2, 2013, Pages 47-59

  Bhatia, Amit ^a   Singh, Bhupinder ^b   Raza, Kaisar ^b   Wadhwa, Sheetu ^b   Katare, Om Prakash ^b  

^a LOVELY PROFESSIONAL UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Design of experiments; Drug delivery; Formulation by design; Gels; Poloxamer; Response surface methodology

Indexed keywords

LECITHIN ORGANOGEL; ORGANIC SOLVENT; PHOSPHATIDYLCHOLINE; POLOXAMER; TAMOXIFEN; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL COMPOSITION; FLOW KINETICS; GEL; PH; PHASE TRANSITION; PRIORITY JOURNAL; TEMPERATURE; VISCOSITY;

ADMINISTRATION, TOPICAL; DRUG CARRIERS; DRUG DESIGN; DRUG STABILITY; ESTROGEN ANTAGONISTS; GELS; LECITHINS; TAMOXIFEN; TRANSITION TEMPERATURE; VISCOSITY;

EID: 84873700813     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.029     Document Type: Article

References (43)

1. R.Z. Aboofazeli, and M.J. Lawrence Investigations into the formation and characterization of phoshpolipid microemulsions I. Pseudo-ternary phase diagrams of systems containing water-lecithin-alcohol-isopropyl myristate Int. J. Pharm. 93 1993 161 175
2. R.Z. Aboofazeli, and M.J. Lawrence Investigations into the formation and characterization of phospholipid microemulsions II. Pseudoternary phase diagrams of systems containing water-lecithin-isopropyl myristate and alcohol: influence of purity of lecithin Int. J. Pharm. 106 1994 51 61
3. G.P. Agarwal, M. Juneja, S. Agarwal, S.K. Jain, and S.S. Pancholi Preparation and characterization of reverse micelle based organogels of piroxicam Pharmazie 59 2004 191 193
4. S. Basu, U.S. Shivhare, and G.S.V. Raghavan Time dependent rheological characteristics of pineapple jam Int. J. Food Eng. 3 2007 Art. 1
5. A. Bhatia, K. Raza, B. Singh, and O.P. Katare Phospholipid-based formulation with improved attributes of coal tar J. Cosmet. Dermatol. 8 2009 282 288
6. A. Bhatia, B. Singh, S. Bhushan, and O.P. Katare Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line Drug Dev. Ind. Pharm. 36 2010 350 354
7. A. Bhatia, B. Singh, S. Wadhwa, K. Raza, and O.P. Katare Novel phospholipid-based topical formulations of tamoxifen: evaluation for antipsoriatic activity using mouse-tail model Pharm. Dev. Technol. 2013 10.3109/10837450.2013.763260
8. D. Capitani, A.L. Segre, F. Dreher, P. Walde, and P.L. Luisi Multinuclear NMR investigation of phosphatidylcholine organogels J. Phys. Chem. 100 1996 15211 15217
9. E. Cevher, M.A.M. Taha, M. Orlu, and A. Araman Evaluation of mechanical and mucoadhesive properties of clomiphene citrate gel formulations containing carbomers and their thiolated derivatives Drug Dev. 15 2008 57 67
10. F. Dreher, P. Walde, P. Walther, and E. Wehrli Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport J. Control. Release 45 1997 131 140
11. G. Dumortier, J.L. Grossiord, F. Agnely, and J.C. Chaumeil A review of Polaxamer 407 pharmaceutical and pharmacological characteristics Pharm. Res. 23 2006 2709 2728
12. M. George, and R.G. Weiss Low molecular-mass gelators with diyne functional groups and their unpolymerized and polymerized gel assemblies Chem. Mater. 15 2003 2879 2888
13. K. Iwanaga, T. Sumizawa, M. Miyazaki, and M. Kakemi Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds Int. J. Pharm. 388 2010 123 128
14. N. Jibry, R.K. Heenan, and S. Murdan Amphiphilogels for drug delivery: formulation and characterization Pharm. Res. 21 2004 1852 1861
15. R. Kumar, and O.P. Katare Lecithin organogels as a potential phospholipid structured system for topical drug delivery: a review AAPS PharmSciTech 6 2005 E298 E310
16. H. Lessmann, A. Schnuch, J. Geier, and W. Uter Skin-sensitizing and irritant properties of propylene glycol Contact Dermatitis 53 2005 247 259
17. S. Loret, G. Nollevaux, R. Remacle, M. Klimek, I. Barakat, P. Deloyer, C. Grandfils, and G. Dandrifosse Analysis of peg 400 and 4000 in urine for gut permeability assessment using solid phase extraction and gel permeation chromatography with refractometric detection J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 805 2004 195 202
18. J. Maenpaa, T. Dooley, G. Wurz, J. Vandeberg, E. Robinson, V. Emshoff, P. Sipila, V. Wiebe, C. Day, and M. Degregorio Topical toremifene: a new approach for cutaneous melanoma? Cancer Chemother. Pharmacol. 32 1993 392 395
19. C. Nastruzzi, and R. Gambari Antitumour activity of (trans)dermally delivered aromatic tetra-amidines J. Control. Release 29 1994 53 62
20. C.K. Osborne Tamoxifen in the treatment of breast cancer N. Engl. J. Med. 339 1998 1609 1618
21. M.G. Page, and G.G. Warr Structure and dynamics of self-assembling aluminum didodecyl phosphate organogels J. Phys. Chem. B 108 2004 16983 16989
22. M. Pandey, V. Belgamwar, S. Gattani, S. Surana, and A. Tekade Pluronic lecithin organogel as a topical drug delivery system Drug Deliv. 17 2010 38 47
23. T. Peinzes, I. Csoika, and I. Eros Rheological analysis of the structural properties effecting the percutaneous absorption and stability in pharmaceutical organogels Rheol. Acta 43 2004 457 463
24. K. Raza, O.P. Katare, A. Setia, A. Bhatia, and B. Singh Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsome J. Microencapsul. 2012 10.3109/02652048.2012.717115
25. K. Raza, B. Singh, P. Singal, S. Wadhwa, and O.P. Katare Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne Colloids Surf. B: Biointerfaces 2013 10.1016/j.colsurfb.2012.12.043
26. H. Richards, C.P. Thomas, J.L. Bowen, and C.M. Heard In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a Pluronic lecithin organogel vehicle containing fish oil J. Pharm. Pharmacol. 58 2006 903 908
27. R. Scartazzini, and P.L. Luisi Organogels from lecithins J. Phys. Chem. 92 1988 829 833
28. J.B. Schwartz, and R.E. Connor Optimization techniques in pharmaceutical formulation and processing G.S. Banker, C.T. Rhodes, Modern Pharmaceutics 3rd ed. 1996 Marcel Dekker Inc. New York 727 752
29. I.M. Shaikh, K.R. Jadhav, P.S. Gide, V.J. Kadam, and S.S. Pisal Topical delivery of aceclofenac from lecithin organogels: preformulation study Curr. Drug Deliv. 3 2006 417 427
30. Y.A. Shchipunov Lecithin organogel: a micellar system with unique properties Colloids Surf. A: Physicochem. Eng. Asp. 183-185 2001 541 554
31. Y.A. Shchipunov, and P. Schmiedel Electrorheological phenomena in lecithin-decane-water mixtures J. Colloid Interf. Sci. 179 1996 201 206
32. Y.A. Shchipunov, and E.V. Shumilina Lecithin bridging by hydrogen bonds in the organogel Mater. Sci. Eng. C3 1995 43 50
33. B. Singh, M. Dahiya, V. Saharan, and N. Ahuja Optimizing drug delivery systems using design of experiments Part II: retrospect and prospects Crit. Rev. Ther. Drug Carrier Syst. 22 2005 215 292
34. B. Singh, R. Kapil, M. Nandi, and N. Ahuja Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects Expert Opin. Drug Deliv. 8 2011 341 360
35. B. Singh, R. Kumar, and N. Ahuja Optimizing drug delivery systems using "design of experiments" Part 1: fundamental aspects Crit. Rev. Ther. Drug Carrier Syst. 22 2005 27 106
36. M. Surjyanarayan, S.S. Mandal, and K.K. Sawant Lecithin stabilized organogel: design and development for topical application of clobetasol propionate Int. J. ChemTech Res. 2 2010 1214 1219
37. T. Tamura, and M. Ichikawa Effect of lecithin on organogel formation of 12-hydroxystearic acid J. Am. Oil Chem. Soc. 74 1997 491 495
38. M. Tarutani, Y. Imai, K. Yasuda, H. Tsutsui, K. Nakanishi, and K. Yamanishi Neutrophil-dominant psoriasis-like skin inflammation induced by epidermal-specific expression of Raf in mice J. Dermatol. Sci. 58 2010 28 35
39. K.K. Upadhyay, C. Tiwari, A.J. Khopade, H.B. Bohidar, and S.K. Jain Sorbitan ester organogels for transdermal delivery of sumatriptan Drug Dev. Ind. Pharm. 33 2007 617 625
40. A. Vintiloiu, and J.C. Leroux Organogels and their use in drug delivery-a review J. Control. Release 125 2008 179 192
41. K. Zhao, S. Singh, and J. Singh Effect of menthone on the in vitro percutaneous absorption of tamoxifen and skin reversibility Int. J. Pharm. 219 2001 177 181
42. Y.L. Zhao, I. Aprahamian, A. Trabolsi, N. Erina, and J.F. Stoddart Organogel formation by a cholesterol-stoppered bistable rotaxane and its dumbbell precursor J. Am. Chem. Soc. 130 2008 6348 6350
43. P. Zhu, X. Yan, Y. Su, Y. Yang, and J. Li Solvent-induced structural transition of self-assembled dipeptide: from organogels to microcrystals Chem. Eur. J. 16 2010 3176 3183